 BASKING RIDGE, NJ, Sept. 10, 2021 GLOBE NEWSWIRE -- via NewMediaWire Timber Pharmaceuticals, Inc. Timber or the Company NYSE American: TMBR, a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that it will present at the H.C. Wainwright 23rd Annual Global Investment Conference. The Conference will be held virtually with all participants joining remotely from September 13th - 15th, 2021. 